In the fourth part of his Pharma Commerce video interview, Sean O’Hearen, founder and principal consultant at 1st Line ...

The study reveals that resilience varies significantly by race, education, income, and insurance status, highlighting the ...

In the third part of his Pharma Commerce video interview, Murray Aitken, executive director, IQVIA Institute for Human Data ...

Pharma prepares for looming tariffs, as the US president signals a phased increase starting Aug. 1, but the official starting ...

In the fourth part of this roundtable discussion, a panel of subject matter experts dive into data exchange challenges relating to the Drug Supply Chain Security Act.

The agreement grants LEO Pharma exclusive rights to the branded form of spesolimab for generalized pustular psoriasis and ...

A panel of key opinion leaders consider how payers and manufacturers are increasingly embracing innovative contracting models ...

In the fourth part of his Pharma Commerce video interview, Murray Aitken, executive director, IQVIA Institute for Human Data Science, outlines what he anticipates for the biosimilar adoption curve in ...

Bruce Leuchter, CEO, Neurvati, explains how industry and advocacy groups can work together to ensure patient and caregiver ...

Industry experts react to the developer’s role in preparing for value-based contracting, acknowledging that innovative agreements can support access when evidence is still maturing.

The industry veteran will lead the company’s next phase of growth, focusing on faster treatment initiation through integrated ...

Inside the GLP-1 Strategy Driving Competitive Edge in Obesity Clinical Research In an interview with Applied Clinical Trials, Shipra Patel, global therapeutic area section head for endocrinology and ...